'Mutation carriers' presentation slideshows

Mutation carriers - PowerPoint PPT Presentation

How to set up a high risk clinic

How to set up a high risk clinic

How to set up a high risk clinic. Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital Breast Center. Problems to solve. Most high risk women not identified

★ ★ ★ ★ ★

1.73k views • 159 slides
How to set up a high risk clinic

How to set up a high risk clinic

How to set up a high risk clinic. Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital Breast Center. Problems to solve. Most high risk women not identified

★ ★ ★ ★ ★

1.6k views • 159 slides
A Report from SABCS Up-to-Date Review of the Treatment of Advanced Breast Cancer

A Report from SABCS Up-to-Date Review of the Treatment of Advanced Breast Cancer

A Report from SABCS Up-to-Date Review of the Treatment of Advanced Breast Cancer. William J. Gradishar, MD Director, Breast Medical Oncology Professor of Medicine Robert H. Lurie Comprehensive Cancer Center Northwestern University Feinberg School of Medicine Chicago, IL.

★ ★ ★ ★ ★

537 views • 38 slides
Diagnostic Testing for Familial Pancreatitis

Diagnostic Testing for Familial Pancreatitis

Diagnostic Testing for Familial Pancreatitis. Emma McCarthy Clinical Scientist Merseyside & Cheshire Regional Molecular Genetics Laboratory. Aims. Overview of pancreatitis both hereditary and idiopathic Genes involved & diagnostic service PRSS1 dosage analysis. Pancreatitis.

★ ★ ★ ★ ★

416 views • 19 slides
Gelmon KA et al. Proc ASCO 2010;Abstract 3002.

Gelmon KA et al. Proc ASCO 2010;Abstract 3002.

Can We Define Tumors That Will Respond to PARP Inhibitors? A Phase II Correlative Study of Olaparib in Advanced Serous Ovarian Cancer and Triple-Negative Breast Cancer. Gelmon KA et al. Proc ASCO 2010;Abstract 3002. Introduction.

★ ★ ★ ★ ★

347 views • 13 slides
The Inhibition of Polymerase in Tumors from BRCA Mutation Carriers

The Inhibition of Polymerase in Tumors from BRCA Mutation Carriers

The Inhibition of Polymerase in Tumors from BRCA Mutation Carriers. Background. Inhibiting polyADP polymerase is key in the treatment of cancers that have DNA-repair defects. Methods.

★ ★ ★ ★ ★

152 views • 5 slides

View Mutation carriers PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Mutation carriers PowerPoint presentations. You can view or download Mutation carriers presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.